← Back to guidelines
Toxicology6 papers

Non-intestinal coccidial infection

Last edited:

Overview

Non-intestinal coccidial infections, particularly those caused by Eimeria species such as Eimeria tenella, primarily affect poultry, notably broiler chicks. These infections are characterized by significant morbidity and economic losses due to reduced growth rates, increased mortality, and compromised flock health. Unlike intestinal coccidial infections, which predominantly affect the gut, non-intestinal manifestations can involve other organs, though they are less commonly reported. The primary focus remains on the intestinal form, especially E. tenella, which causes severe hemorrhagic enteritis. Understanding the pathophysiology, diagnosis, management, and complications associated with these infections is crucial for effective control and treatment strategies. This guideline synthesizes current evidence to provide clinicians with a comprehensive approach to managing non-intestinal coccidial infections, with a particular emphasis on E. tenella.

Pathophysiology

The life cycle of Eimeria tenella involves several critical stages that contribute significantly to the pathogenesis of coccidial infections in chickens. The process begins with the ingestion of sporulated oocysts, which release sporozoites in the intestinal lumen. These sporozoites invade the intestinal epithelial cells, initiating merogony, where they multiply asexually within the host cells, leading to cellular damage and the formation of schizonts. Subsequently, gametogony occurs, resulting in the production of new oocysts that are shed in the feces, perpetuating the cycle [PMID:41477966]. This sequential invasion and proliferation cause extensive hemorrhagic enteritis, characterized by bloody diarrhea, reduced feed intake, and significant morbidity in affected flocks.

Nutritional deficiencies, particularly in essential amino acids like threonine, exacerbate the severity of coccidial infections. A study demonstrated that broiler chicks fed a threonine-deficient diet (0.49%) exhibited worsened intestinal damage and increased oocyst shedding when challenged with coccidial vaccines, compared to those on a control diet (0.90% threonine) [PMID:27993179]. This deficiency impairs the intestinal barrier function and immune response, making the birds more susceptible to the pathogenic effects of E. tenella. The compromised barrier integrity not only facilitates easier invasion by sporozoites but also hinders the effective clearance of the parasite, leading to higher morbidity and mortality rates.

Diagnosis

Diagnosing non-intestinal coccidial infections, particularly those caused by E. tenella, often relies on clinical signs, post-mortem examinations, and laboratory diagnostics. While intestinal coccidial infections are more straightforward to diagnose due to overt gastrointestinal symptoms, non-intestinal manifestations may present more subtly. Key diagnostic approaches include:

  • Clinical Signs and Post-Mortem Examination: Hemorrhagic enteritis and gross lesions in the ceca are hallmark signs of E. tenella infection. Histopathological examination of affected tissues can reveal characteristic schizonts and tissue damage, aiding in definitive diagnosis [PMID:41477966].
  • Oocyst Detection: Fecal examination using flotation techniques remains a standard method to detect oocysts. However, the specificity and sensitivity can be enhanced by identifying specific biomarkers associated with the infection. The study by [PMID:41477966] highlights the potential of inflammatory cytokines (e.g., IL-1β, TNF-α) and barrier protein genes (e.g., occludin, ZO-1) as biomarkers. Elevated levels of these cytokines and reduced expression of barrier proteins in cecal tissue can indicate active E. tenella infection, providing valuable insights for monitoring disease progression and treatment efficacy.
  • In clinical practice, integrating histopathological scoring and the Anticoccidial Index (ACI) offers a robust framework for assessing the severity and impact of the infection. These metrics help in evaluating the overall health status of the flock and guiding therapeutic interventions [PMID:41477966].

    Management

    Effective management of E. tenella infections involves a multifaceted approach encompassing preventive measures, supportive care, and targeted therapeutic interventions. Given the increasing prevalence of drug resistance among conventional anticoccidial agents like diclazuril, exploring alternative and sustainable treatment options is imperative.

    Preventive Strategies

  • Vaccination: Implementing coccidial vaccines can reduce the severity and incidence of infections. However, their efficacy can be compromised by nutritional deficiencies, such as threonine deficiency, which impair immune responses and barrier function [PMID:27993179]. Ensuring optimal nutritional status, particularly in essential amino acids, is crucial for maximizing vaccine effectiveness.
  • Nutritional Management: Maintaining adequate levels of essential nutrients, especially threonine, is vital. Birds fed a threonine-deficient diet (0.49%) exhibit significantly reduced body weight gain and increased oocyst shedding compared to those on a balanced diet (0.90% threonine), underscoring the importance of proper nutrition in preventing severe infections [PMID:27993179].
  • Therapeutic Interventions

  • Natural Anticoccidial Agents: Anemoside B4 (AB4) has emerged as a promising natural anticoccidial agent. Studies indicate that AB4 ameliorates E. tenella-induced intestinal damage through immunomodulatory effects, anti-inflammatory actions, and enhanced barrier repair mechanisms [PMID:41477966]. These properties suggest that AB4 could serve as a safer and more sustainable alternative to conventional drugs, particularly in flocks with resistance to traditional anticoccidial therapies.
  • Supportive Care: Ensuring optimal hydration, electrolyte balance, and providing supportive nutrition are essential components of managing affected flocks. This includes administering electrolyte solutions and adjusting feed formulations to meet increased nutritional demands during recovery.
  • Monitoring and Follow-Up

    Regular monitoring of clinical signs, fecal oocyst counts, and biomarker levels (e.g., inflammatory cytokines, barrier protein expression) is crucial for assessing treatment efficacy and disease progression. Histopathological scoring and the Anticoccidial Index (ACI) provide valuable metrics for evaluating long-term prognosis and guiding follow-up interventions [PMID:41477966]. These assessments help in adjusting treatment strategies and ensuring sustained recovery and flock health.

    Complications

    Non-intestinal coccidial infections, particularly those caused by E. tenella, can lead to several complications that significantly impact flock health and productivity. Key complications include:

  • Severe Hemorrhagic Enteritis: The hallmark of E. tenella infection, characterized by extensive damage to the intestinal mucosa, leading to bloody diarrhea and dehydration. This condition not only affects immediate survival but also long-term growth performance [PMID:41477966].
  • Impaired Nutrient Absorption: Damage to the intestinal barrier function impairs nutrient absorption, contributing to reduced body weight gain and poor growth performance. Threonine deficiency exacerbates this issue, further compromising the birds' ability to recover and thrive [PMID:27993179].
  • Immune Dysregulation: The infection triggers a robust but often dysregulated immune response, characterized by elevated inflammatory cytokines. This dysregulation can lead to systemic inflammation and further tissue damage, complicating recovery and increasing susceptibility to secondary infections [PMID:41477966].
  • Increased Oocyst Shedding: Higher oocyst shedding not only indicates active infection but also poses a significant risk of horizontal transmission within flocks, perpetuating the cycle of infection and necessitating stringent biosecurity measures.
  • These complications underscore the importance of early diagnosis and aggressive management strategies to mitigate their impact and ensure the overall health and productivity of the flock.

    Key Recommendations

  • Optimize Nutrition: Ensure diets are balanced, particularly in essential amino acids like threonine, to support immune function and intestinal barrier integrity.
  • Implement Vaccination Programs: Use coccidial vaccines strategically, considering nutritional status to enhance efficacy.
  • Explore Natural Therapeutics: Consider the use of natural anticoccidial agents like AB4 as part of a sustainable treatment regimen, especially in flocks with resistance to conventional drugs.
  • Regular Monitoring: Employ histopathological scoring, ACI, and biomarker assessments to monitor disease progression and treatment outcomes effectively.
  • Supportive Care: Provide adequate hydration, electrolyte balance, and nutritional support to enhance recovery and mitigate complications.
  • By adhering to these recommendations, clinicians can better manage non-intestinal coccidial infections, particularly those caused by E. tenella, ensuring improved flock health and productivity.

    References

    1 Yang M, Han H, Zheng Z, Xin Q, Zhang B, Yu T et al.. Anemoside B4 attenuates intestinal damage in chickens infected with Eimeria tenella: Mechanisms involving antioxidant defense, immune modulation, and barrier repair. Poultry science 2026. link 2 Zhang Q, Chen X, Eicher SD, Ajuwon KM, Applegate TJ. Effect of threonine deficiency on intestinal integrity and immune response to feed withdrawal combined with coccidial vaccine challenge in broiler chicks. The British journal of nutrition 2016. link

    2 papers cited of 6 indexed.

    Original source

    1. [1]
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG